USA - NASDAQ:YI - US68247Q2012 - ADR
The current stock price of YI is 3.9 USD. In the past month the price decreased by -14.02%. In the past year, price decreased by -36.22%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| GRDN | GUARDIAN PHRMCY SERVICES-A | N/A | 1.77B | ||
| MGRX | MANGOCEUTICALS INC | N/A | 13.49M | ||
| SRXH | SRX HEALTH SOLUTIONS INC | N/A | 6.54M |
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai and currently employs 1,238 full-time employees. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.
111 INC
3-4/F, No.295 Zuchongzhi Road, Pudong New Area
Shanghai SHANGHAI 201203 CN
CEO: Junling Liu
Employees: 1520
Phone: 862120536666
111, Inc. Is a holding company, which engages in the provision of pharmaceutical products and medical services through online retail pharmacy and indirectly through offline pharmacy network. The company is headquartered in Shanghai, Shanghai and currently employs 1,238 full-time employees. The company went IPO on 2018-09-12. The firm mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The firm also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The firm mainly conducts its business in the domestic market.
The current stock price of YI is 3.9 USD. The price increased by 0.04% in the last trading session.
YI does not pay a dividend.
YI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
The outstanding short interest for 111 INC (YI) is 0.4% of its float.
ChartMill assigns a fundamental rating of 3 / 10 to YI. YI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months YI reported a non-GAAP Earnings per Share(EPS) of -5.78. The EPS increased by 90.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -2.63% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |